Endonovo Therapeutics, Inc.
ENDV
$0.0002
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -766.20K | 2.06M | 7.23M | -12.93M | -603.40K |
| Total Depreciation and Amortization | 161.70K | 161.70K | 161.70K | 161.70K | 161.70K |
| Total Amortization of Deferred Charges | -2.60K | 10.80K | 3.90K | 20.20K | 31.30K |
| Total Other Non-Cash Items | 247.60K | -2.90M | -8.03M | 12.21M | -262.90K |
| Change in Net Operating Assets | 294.10K | 500.30K | 456.00K | 317.70K | 549.40K |
| Cash from Operations | -65.40K | -165.80K | -173.20K | -225.50K | -123.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 49.00K | 146.00K | -- | 65.00K | 150.00K |
| Total Debt Repaid | -20.00K | -4.50K | -23.00K | -4.50K | -3.00K |
| Issuance of Common Stock | 3.80K | 46.00K | 207.00K | 142.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 32.80K | 187.50K | 184.00K | 202.50K | 147.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -32.60K | 21.70K | 10.80K | -23.00K | 23.10K |
